Intra-Cellular Therapies Inc. (ITCI) News
Filter ITCI News Items
ITCI News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
ITCI News Highlights
- ITCI's 30 day story count now stands at 8.
- Over the past 24 days, the trend for ITCI's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- The most mentioned tickers in articles about ITCI are BIIB, CRSP and DEC.
Latest ITCI News From Around the Web
Below are the latest news stories about INTRA-CELLULAR THERAPIES INC that investors may wish to consider to help them evaluate ITCI as an investment opportunity.
11 Most Promising Psychedelic Stocks According to Hedge FundsIn this piece, we will take a look at the 11 most promising psychedelic stocks according to hedge funds. If you want to skip our overview of the psychedelic industry and the latest news, then you can take a look at the 5 Most Promising Psychedelic Stocks. The ability to use chemicals to alter one’s […] |
Intra-Cellular Therapies (ITCI) is a Great Momentum Stock: Should You Buy?Does Intra-Cellular Therapies (ITCI) have what it takes to be a top stock pick for momentum investors? Let's find out. |
3 Biotech Stocks Most Wall Street Analysts Are Bullish AboutHere we present three biotech stocks, CRSP, ITCI and DVAX, which most analysts on Wall Street are optimistic about. These companies have upside potential for 2024, backed by strong fundamentals. |
Intra-Cellular Therapies Inc's EVP, Chief Medical Officer Suresh Durgam Sells 21,262 SharesIn a notable insider transaction, EVP and Chief Medical Officer Suresh Durgam of Intra-Cellular Therapies Inc (NASDAQ:ITCI) sold 21,262 shares of the company's stock on December 13, 2023. |
IBD 50 Stocks To Watch: Biotech Leader Intra-Cellular Therapies Is Breaking Out Past A New Buy PointBiotech leader Intra-Cellular Therapies is breaking out past a new buy point, making it one of the best stocks to buy and watch. |
Why Is Biogen Inc. (BIIB) Up 6.4% Since Last Earnings Report?Biogen Inc. (BIIB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. |
Intra-Cellular Therapies Highlights Data Presentations at the American College of Neuropsychopharmacology Annual MeetingCompany presents positive results of a pre-specified patient population in Study 403 examining the effects of CAPLYTA® (lumateperone) in patients experiencing a major depressive episode with anxious distress and mixed features. Company presents preclinical data on ITI-1549, our lead product candidate in our non-hallucinogenic psychedelics program in mood disorders and other psychiatric disorders. NEW YORK, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biophar |
Wall Street Analysts Think Intra-Cellular (ITCI) Could Surge 33.02%: Read This Before Placing a BetThe mean of analysts' price targets for Intra-Cellular (ITCI) points to a 33% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock. |
15 Developed Countries with Lowest Autism RatesIn this article, we will discuss 15 developed countries with lowest autism rates. If you want to skip our discussion on the autism industry, you can go directly to the 5 Developed Countries with Lowest Autism Rates. According to Fortune Business Insights, the autism spectrum disorder market was assessed at $1.93 billion in 2022. The […] |
Intra-Cellular Therapies to Present at the 6th Annual Evercore ISI HealthCONx ConferenceNEW YORK, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that it will present at the 6th Annual Evercore ISI HealthCONx Conference on Tuesday, November 28, 2023 at 3:25 p.m. ET in Miami, FL. The live and archived webcast can be accessed under "Events & Presentations" in the Investor Relations section of the Comp |